Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Raymond C. James"'
Autor:
Tanya Simuni, Holly A. Shill, Matthew Brodsky, Marcie Rabin, Michael A. Schwarzschild, Kenneth Marek, Cheryl Waters, Cindy Casaceli, Steven A. Gunzler, Stephen G. Reich, Codrin Lungu, Sarah Elizabeth Zauber, Kellie Keith, Shyamal H. Mehta, Dariush Mozaffarian, Valerie Suski, Marie Saint-Hilaire, John L. Goudreau, Alice Rudolph, Ruth B. Schneider, Aaron Daley, Eric A. Macklin, Zoltan Mari, Grace F. Crotty, Andres Deik, Alberto J. Espay, Ashley Laroche, Sherri Mosovsky, Joohi Jimenez-Shahed, Mark S. LeDoux, Cynthia Poon, Ashley Gerald, John C. Morgan, Carolyn Peterson, Joseph H. Friedman, David Klements, Robert A. Hauser, Doozie Russell, David Simon, Kathrin LaFaver, Vanessa K. Hinson, Richard B. Dewey, Melissa Ainslie, Jason Aldred, Tiago A. Mestre, John Y. Fang, Liana S. Rosenthal, Grace Bwala, Raymond C. James, Binit B. Shah, Gearoid M. McMahon, Ariane Park, Rajeev Kumar, Lin Zhang, Ivan Bodis-Wollner, Mya C. Schiess, Katherine F. Callahan, David Oakes, Kelvin L. Chou, Melissa Kostrzebski, Roger Kurlan, Lisa Gauger, Albert Y. Hung, Melissa Bixby, Ira Shoulson, Michael Soileau, James T. Boyd, Peter A LeWitt, Burton L. Scott, Claire Henchcliffe, Patricia Kaminski, Alberto Ascherio, Cornelia Kamp, Lindsay Pothier, Anwar Ahmed, Jill Ciccarello, David J. Houghton, April Langhammer, Rebecca Fitzgerald, Maureen A. Leehey, Anthony E. Lang, Carmen Serrano, Martha McGraw, David Shprecher, Jennifer Durphy, Aleksandar Videnovic, Danish Bhatti, Christine Hunter, Amber Servi Ratel, J. Antonelle de Marcaida, Christopher G. Goetz, Emily Houston, Rajesh Pahwa, Chadwick W. Christine, Gary C. Curhan, Irene Litvan, Christopher A. Beck, Leslie J. Cloud, Patrick Bolger, Karen Thomas, Natividad Stover, Karen Blindauer, Sushrut S. Waikar, Susan R. Criswell
Publikováno v:
JAMA
IMPORTANCE: Urate elevation, despite associations with crystallopathic, cardiovascular, and metabolic disorders, has been pursued as a potential disease-modifying strategy for Parkinson disease (PD) based on convergent biological, epidemiological, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4608ea519947a922d23da1991ccca9
https://europepmc.org/articles/PMC8441591/
https://europepmc.org/articles/PMC8441591/
Autor:
Alberto Ascherio, Elmyra Encarnacion, Cathi-Ann Thomas, Doozie Russell, Marsha Tennis, Grace Bwala, Jayaraman Rao, Charlise Hope-Porche, Albert Y. Hung, Saloni Sharma, Maureen Gartner, Eric A. Macklin, Joshua M. Hare, Constance Orme, Candace Cotto, Stuart Isaacson, Sheila Thurlow, Lauren McClurg, Marie Saint-Hilaire, Lisa Niles, Tori Ross, Lisbeth Carvajal, Megan Murray, Joseph Weber, M. Flint Beal, Robert Logan, Alicia Brocht, Michael A. Schwarzschild, Richard Lenehan, David Oakes, Sotirios A. Parashos, Ken Eaton, David S. Russell, Merit Cudkowicz, D. Craig Hooper, Christopher G. Goetz, Ira Shoulson, Alberto J. Espay, Karl Kieburtz, Daniel M. Togasaki, Gina Barles, Daniela L. Grasso, John L. Goudreau, Alice Rudolph, Jeana Jaglin, Patricia Ede, Gary C. Curhan, Maureen Cook, Joseph H. Friedman, Richard Castillo, Lisa Gauger, Radu Constantinescu, Charles S. Venuto, Mark Stacy, Anwar Ahmed, Julia H R Johnson, Julie H. Carter, Melissa Ainslie, Raymond C. James, J. Antonelle de Marcaida
Publikováno v:
JAMA neurology. 71(2)
Convergent biological, epidemiological, and clinical data identified urate elevation as a candidate strategy for slowing disability progression in Parkinson disease (PD).To determine the safety, tolerability, and urate-elevating capability of the ura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29ba3a47b0201bc035e618808ce57d45
https://pubmed.ncbi.nlm.nih.gov/24366103
https://pubmed.ncbi.nlm.nih.gov/24366103
Autor:
Neila Mendis, Sherali Esmail, Jenna Smith, Emily Christopher, Charles S. Davis, Elaine Sperin, Victor W. Sung, Fredy J. Revilla, Jane S. Paulsen, Thomas Brashers-Krug, Shirley Eberly, Paola Wall, Andrew P. Duker, Clare Gibbons, Emily Houston, Pierre N. Tariot, Eric Molho, Susan R. Criswell, Marie Saint-Hilaire, Ali Samii, Lori Fafard, Joohi Jimenez-Shahed, Monica Beland, Olivia C. Roman, Blair R. Leavitt, Wai Lun Alan Fung, Greg Suter, Jacquelyn Whaley, Andrew Feigin, Mary Jane Ong, Ramon L. Rodriguez, Samuel Frank, Ronda Clouse, Anna Hohler, Elise Kayson, Russell L. Margolis, Erin Neefus, Laura Graffitti, Andrew McGarry, Sharon Evans, Cynthia A. Wong, Frederick C. Nucifora, Shari Kinel, Joseph Jankovic, Daniel Schneider, Arthur Watts, Margaret Herzog, Cory Hackmyer, Denyse Turpin, David Shprecher, Joanne Wojcieszek, Patrick Hickey, David Oakes, Karen Blindauer, Constance Orme, Christina L. Vaughan, Karen E. Anderson, Carlos Singer, Stewart A. Factor, Mary Eglow, Rajeev Kumar, Kathrin La Faver, Brad A. Racett, Victoria Snively, Mark Gudesblatt, Tilak Mendis, Mary Edmondson, Christine Hunter, Rohit Dhall, Christine O'Neill, James T. Boyd, Christopher A. Beck, Sylvain Chouinard, Lina Qi, Jon Edicola, Lynn Wheeler, Sarah Janicki, Burton L. Scott, Amanda Miller, Hilary E. Wilson-Pérez, Claudia M. Testa, Raymond C. James, Jody Goldstein, Pinky Agarwal, Richard Dubinsky, Eric S. Farbman, Jane Kerr, David Stamler, Carolyn Gray, Kevin Klos, Daniel O. Claassen, Kyle Rizer, Alexis Carlson, Hope Heller, Amy Colcher, Scott R. Evans, Monica Quesada, Christina Reeves
Publikováno v:
JAMA. 316:40
Importance Deutetrabenazine is a novel molecule containing deuterium, which attenuates CYP2D6 metabolism and increases active metabolite half-lives and may therefore lead to stable systemic exposure while preserving key pharmacological activity. Obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abb9776d67c95630906f9e10a5561de6
https://doi.org/10.1001/jama.2016.8655
https://doi.org/10.1001/jama.2016.8655
Autor:
Anna Hohler, Rachel Saunders-Pullman, Robert A. Hauser, M.B. Stern, Liza Reys, Valerie Iannucci, Maria R. Albelo, Danna Jennings, Donna Miles, Emily Borushko, Linda McGinn, Irene H. Richard, Jacqueline Rick, Grace S. Liang, Indu Subramanian, Abby Fiocco, Cheryl Deely, Kapil D. Sethi, Angelina Gratiano, Amy Duffy, Matthew B. Stern, Shirley Lasch, Kathryn A. Chung, Andrew Siderowf, Keith A. Hawkins, Shirley Eberly, Cathi A. Thomas, Shawna Johnson, Eugene Lai, Marian L. Evatt, Kenneth Marek, Albert Ascherio, Leyla Khavarian, Emily Virden, Candace Cotto, Brenna M. Lobb, Farah Atassi, Paula Jackson, Brian Howard, Susan O'Conner, Carolyn Cioffi, Michael E. DeBakey, Charles H. Adler, Theresa McClain, Tanya Simuni, Samuel Frank, David W. Russell, David Oakes, Katrina Miles, Allison Gadoury, Gary Wisniewski, Susan Mendick, Raymond C. James
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 27(3)
To test the association between impaired olfaction and other prodromal features of PD in the Parkinson At-Risk Syndrome Study. The onset of olfactory dysfunction in PD typically precedes motor features, suggesting that olfactory testing could be used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d64331e069756941714ff68b43eb36b3
https://pubmed.ncbi.nlm.nih.gov/22237833
https://pubmed.ncbi.nlm.nih.gov/22237833